Nur Ink Innovations Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
NURI
IL0011757288
Specialty Chemicals
Sales 2022 | - | Sales 2023 | - | Capitalization | 53.72M 198M 4.26B |
---|---|---|---|---|---|
Net income 2022 | -11M -40.51M -873M | Net income 2023 | -12M -44.19M -952M | EV / Sales 2022 | - |
Net cash position 2022 | 17.77M 65.43M 1.41B | Net cash position 2023 | 7.22M 26.61M 573M | EV / Sales 2023 | - |
P/E ratio 2022 |
-13.6
x | P/E ratio 2023 |
-
| Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 48.32% |
Managers | Title | Age | Since |
---|---|---|---|
Moshe Nur
CEO | Chief Executive Officer | 74 | 13/11/18 |
David Gerbi
DFI | Director of Finance/CFO | 44 | 25/01/21 |
Moshe Nakash
CTO | Chief Tech/Sci/R&D Officer | 60 | 08/03/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 01/09/19 | |
Sarel Ashkenazi
BRD | Director/Board Member | 51 | 25/01/21 |
Moshe Nur
CEO | Chief Executive Officer | 74 | 13/11/18 |
1st Jan change | Capi. | |
---|---|---|
+9.17% | 4B | |
+23.05% | 1.1B | |
+8.03% | 1.02B | |
+36.50% | 762M | |
+65.59% | 748M | |
-3.86% | 684M | |
+32.41% | 611M | |
+24.52% | 506M | |
+11.45% | 479M |